MillerSandbox1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 16: Line 16:


== Medical Applications ==
== Medical Applications ==
During the times of COVID-19, which appeared in the year 2020, pneumonia is one of the biggest worries a person could develop while having the upper respiratory infection. The most common type of bacteria that causes an upper respiratory infection is the Streptococcus pneumoniae bacterium, and it is also the most common culprit of septicemia and meningitis (Structure and function). While contracting one of these infections, the CRP will bind to the bacteria through the "Ca2+ dependent reactions with PCh residues" on the bacterial cell walls (Structure and function). Structurally, PCh is widely distributed inside and outside of pathogens and in the cellular membranes, which allows CRP to recognize a wide range of pathogenic targets and damaged host cells. This reaction raises the CRP levels within the serum of human blood, allowing for a laboratory test to detect the elevated levels of CRP, indicating that an infection or inflammatory response is occurring within the body.
During the times of COVID-19, which appeared in the year 2020, pneumonia is one of the biggest worries a person could develop while having the upper respiratory infection. The most common type of bacteria that causes an upper respiratory infection is the Streptococcus pneumoniae bacterium, and it is also the most common culprit of septicemia and meningitis <ref name=Structure>Gang TB, Hanley GA, Agrawal A. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms. Infection and Immunity. 2015 May;83(5):1845-1852. DOI: 10.1128/IAI.03058-14.</ref>. While contracting one of these infections, the CRP will bind to the bacteria through the "Ca2+ dependent reactions with PCh residues" on the bacterial cell walls <ref name=Structure/>. Structurally, PCh is widely distributed inside and outside of pathogens and in the cellular membranes, which allows CRP to recognize a wide range of pathogenic targets and damaged host cells. This reaction raises the CRP levels within the serum of human blood, allowing for a laboratory test to detect the elevated levels of CRP, indicating that an infection or inflammatory response is occurring within the body.


Human C-reactive protein plays a significant role in the acute phase of defense against pathogens. CRP will specifically bind to the damaged membranes of host cells where there is "an increased proportion of Lysophospholipid'' (Thompson et. al). The ability of CRP to contribute to the innate immunity within the body allows for it also to prevent autoimmunity (Thompson et. al). It has also been discovered that CRP is a crucial indicator in the complications or outcomes of an individual after suffering a myocardial infarction (heart attack) where "CRP will deposit into the infarcted tissue, and it activates complement" (Thompson et. al). This response triggers the body's "classical complement pathway of innate immunity by activating C1q" <ref name=Evolution/>. The activation of this innate immunity allows for the body to start the healing process within the localized area.
Human C-reactive protein plays a significant role in the acute phase of defense against pathogens. CRP will specifically bind to the damaged membranes of host cells where there is "an increased proportion of Lysophospholipid'' <ref name=Thompson>Thompson, Darren, et al. “The Physiological Structure of Human C-Reactive Protein and Its Complex with Phosphocholine.” Structure, Cell Press, 22 July 2004, www.sciencedirect.com/science/article/pii/S0969212699800239</ref>. The ability of CRP to contribute to the innate immunity within the body allows for it also to prevent autoimmunity <ref name=Thompson/>. It has also been discovered that CRP is a crucial indicator in the complications or outcomes of an individual after suffering a myocardial infarction (heart attack) where "CRP will deposit into the infarcted tissue, and it activates complement" <ref name=Thompson/>.. This response triggers the body's "classical complement pathway of innate immunity by activating C1q" <ref name=Evolution/>. The activation of this innate immunity allows for the body to start the healing process within the localized area.
          
          
However, CRP levels vary amongst a wide variety of infections or injuries. CRP levels can diminish over 18-20 hours after the stimuli has ended, and the levels can continue to increase if there is a more serious underlying condition such as progressive cancer <ref name=Evolution/>. There are also many more factors that alter the baseline levels of CRP within the body that include "age, gender, smoking status, weight, blood pressure, and lipid levels'' <ref name=Evolution/>. Baseline CRP levels of an individual can be found around a level of 0.8mg/L in a healthy Caucasian, "but this baseline can vary greatly in individuals due to [the] other factors, [also] including polymorphisms in the CRP gene" <ref name=Evolution/>. Although polymorphisms have been found with the CRP gene, "there are no allelic variations or genetic deficiencies discovered for this gene" <ref name=Evolution/>. A study was conducted with twins that "showed significant heritable components in [the] baseline CRP values that are independent of age and body mass index"<ref name=Evolution/>. The study concluded that the CRP levels are roughly 35-40% heritable <ref name=Evolution/>. It is known that CRP levels are elevated due to disease, so the levels cannot be directly reduced through the administration of drugs, but rather, by directly treating the underlying medical condition.
However, CRP levels vary amongst a wide variety of infections or injuries. CRP levels can diminish over 18-20 hours after the stimuli has ended, and the levels can continue to increase if there is a more serious underlying condition such as progressive cancer <ref name=Evolution/>. There are also many more factors that alter the baseline levels of CRP within the body that include "age, gender, smoking status, weight, blood pressure, and lipid levels'' <ref name=Evolution/>. Baseline CRP levels of an individual can be found around a level of 0.8mg/L in a healthy Caucasian, "but this baseline can vary greatly in individuals due to [the] other factors, [also] including polymorphisms in the CRP gene" <ref name=Evolution/>. Although polymorphisms have been found with the CRP gene, "there are no allelic variations or genetic deficiencies discovered for this gene" <ref name=Evolution/>. A study was conducted with twins that "showed significant heritable components in [the] baseline CRP values that are independent of age and body mass index"<ref name=Evolution/>. The study concluded that the CRP levels are roughly 35-40% heritable <ref name=Evolution/>. It is known that CRP levels are elevated due to disease, so the levels cannot be directly reduced through the administration of drugs, but rather, by directly treating the underlying medical condition.

Revision as of 17:57, 29 April 2020

Human C-Reactive Protein 1GNH

Caption for this structure

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Adam Miller